THERAPEUTICS EX3 L(?) (ATRIAL FIBRILLATION) (MIRANDA)

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall with Kai
GameKnowt Play
New
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/107

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

108 Terms

1
New cards

Describe a supraventricular arrhythmia

Originates from ABOVE the bundle of His

2
New cards

Types of supraventricular arrhythmias? (four)

1. Afib

2. Aflutter

3. Paroxysmal supraventricular tachycardia

4. Autonomic atrial tachycardia

3
New cards

Describe a ventricular arrhythmia

Originates from BELOW the bundle of His

4
New cards

Types of ventricular arrhythmias? (three)

1. Premature ventricular complexes

2. Ventricular tachycardia

3. Ventricular fibrillation

5
New cards

Define atrial fibrillation

A supraventricular arrhythmia with uncoordinated atrial activation and consequently ineffective atrial contraction

6
New cards

Afib is defined by what kind of heartrate? Bpm?

Chaotic, rapid (300-500 bpm); irregular atrial rhythm

7
New cards

Conditions which predispose a person to Afib?

Advanced age

Smoking

Physical activity

Alcohol

Obesity

Height

Blood pressure (HTN)

Resting heart rate

Diabetes

8
New cards

Cardiovascular conditions which predispose a person to Afib?

HF

CAD

VHD

Cardiac surgery

9
New cards

Acute cases which can precipitate Afib?

Thyrotoxicosis

Surgery

Alcohol withdrawal

Sepsis

Excessive physical exertion

10
New cards

T/F: Afib is a progressive disease.

True

11
New cards

Describe AF Stage 2

Evidence of structural or electrical findings further predisposing a patient to AF

(atrial enlargement, frequent atrial ectopy)

12
New cards

Describe AF Stage 3

Has diagnosed AF

Paroxysmal, persistent, long-standing persistent, or successful AF ablation

13
New cards

Describe AF Stage 4

Permanent AF

14
New cards

Testing used to diagnose AF?

12-lead ECG (gold standard)

Holter/event monitor (paroxysmal)

15
New cards

Afib graph looks like what?

Extra spiky

<p>Extra spiky</p>
16
New cards

Aflutter graph looks like what?

More squiggly in the middle

<p>More squiggly in the middle</p>
17
New cards

What are the FDA-cleared Direct to Consumer monitor types? (four)

Apple Watch

Fitbit sense

Samsung Galaxy Watch 3

Withings ScanWatch

18
New cards

Clinical characteristics of AF?

Palpitations, exertional fatigue, lightheadedness, exercise intolerance, dyspnea

Syncope is possible but uncommon

19
New cards

What are the 4As of AF management?

Access to All Aspects of Care for All

20
New cards

What does SOS stand for in AF management?

Stroke risk

Optimize (modifiable risk factors)

Symptom management

21
New cards

What does HEAD 2 TOES stand for in AF management?

Heart failure, exercise, arterial hypertension, diabetes, tobacco, obesity, ethanol, sleep

These are the most common/pertinent risk factors for AF

22
New cards

Primary prevention recommendations (LRFM) for management of AF?

Patients at increased risk of AF should receive comprehensive guideline-directed LRFM for AF, targeting obesity, physical inactivity, unhealthy alcohol consumption, smoking, diabetes, and hypertension.

23
New cards

What is the recommended percentage weight loss for secondary prevention in AF management?

Target of 10%

24
New cards

What is the recommended weekly physical fitness guideline for secondary prevention in AF management?

210 minutes/wk

25
New cards

Which risk score assessment do we prefer for assessing AF risk?

CHADS-VASc

26
New cards

T/F: For stroke management in Afib, we prefer DOACs over warfarin.

True

27
New cards

DOACs include? (four)

Apixaban

Dabigatran

Edoxaban

Rivaroxaban

28
New cards

T/F: ASA alone or with clopidogrel is an acceptable alternative to DOAC or warfarin in stroke management of AF.

False; only in the presence of another indication

29
New cards

Dosing for apixaban in Afib? Include adjusted dosing and why?

5 mg PO BID

2.5 mg PO BID if patient has any 2 of the following:

Age 80+

Body weight < or equal to 60

SCr > or equal to 1.5

30
New cards

Dabigatran (Pradaxa) dosing in Afib?

150 mg PO BID

31
New cards

Dabigatran (Pradaxa) dosing in Afib patients that have a CrCl of 15-30 mL/min?

75 mg PO BID

32
New cards

Contraindications associated with dabigatran?

Hypersensitivity, active pathological bleeding, mechanical heart valves

33
New cards

Edoxaban dosing in Afib?

60 mg PO daily

34
New cards

Edoxaban dosing in Afib for patients with a CrCl of 15-50 mL/min?

30 mg PO daily

35
New cards

Rivaroxaban dosing in Afib?

20 mg PO daily

With biggest meal

36
New cards

Rivaroxaban dosing in Afib for patients who have a CrCl of 15-50 mL/min?

15 mg PO daily

With biggest meal

37
New cards

What drug is responsible for the reversal of dabigatran?

Idarucizumab

38
New cards

What drug is responsible for the reversal of apixaban, rivaroxaban?

Andexanet alfa (Andexxa)

39
New cards

What drug is responsible for the reversal of acute major bleeding in patients receiving VKAs?

4-Factor PCC (Kcentra)

40
New cards

What drug is responsible for control and prevention of bleeding episodes, and is sometimes use off-label to reverse dabigatran-associated life-threatening bleeds?

Activated PCC

41
New cards

T/F: Most patients will need therapies to control HR, revert to SR, or maintain SR to limit symptoms or improve outcomes; most of these patients require a combination approach.

True

42
New cards

T/F: In older patients, we prefer rate control.

True

43
New cards

What are the three criteria we look for to determine that we prefer rate control over rhythm control?

If a patient is:

Older

Has a longer history of AF

Has fewer symptoms

We prefer rate control

44
New cards

What are the three criteria we look for to determine that we prefer rhythm control over rate control?

If a patient is:

Younger

Has a shorter history of AF

Has more symptoms

We prefer rhythm control

45
New cards

What is our goal HR in Afib patients without HF?

Less than 100-110 bpm

46
New cards

T/F: Non-DHP CCBs should be avoided in HFrEF.

True

47
New cards

Antiarrhythmic medications for rhythm control? (five)

Dofetilide

Donedarone

Flecainide

Propafenone

Sotalol

48
New cards

Non-pharm rhythm control options?

Cardioversion

Catheter ablation

49
New cards

Key features of pharmacological cardioversion?

Success rate varies with agent and duration of AF

No need for general anesthesia

Concerns with side effects/toxicity of AAD

50
New cards

Key features of direct current cardioversion (DCC)?

Associated with higher success rates

Treatment of choice for hemodynamic instability

Need for general anesthesia

51
New cards

T/F: Patients that undergo cardioversion need to be anticoagulated with UFH or LMWH.

True

52
New cards

When is pharmacological cardioversion a reasonable alternative?

For those who are hemodynamically stable, pharmacological cardioversion is a reasonable alternative to electrical cardioversion.

53
New cards

Pharmacological agents used for cardioversion? (four)

Ibutilide (if LVEF > or equal to 40%)

Amiodarone IV (longer to convert)

Flecainide, propafenone

Alternative: IV procainamide

54
New cards

When do we consider maintenance of sinus rhythm?

Reasonable for long-term therapy in those who are not candidates or decline catheter ablation, or prefer antiarrhythmics.

55
New cards

Pharmacological agents used for maintenance of sinus rhythm? (four)

Dofetilide, amiodarone (if LVEF < or equal to 40%)

Flecainide, propafenone (no previous MI, structural heart disease, ventricular scar or fibrosis)

Dronedarone

Alternative: Sotalol

56
New cards

Class Ia antiarrhythmics include? (three)

Disopyramine

Procainamide

Quinidine

57
New cards

Class Ib antiarrhythmics include? (two)

Lidocaine

Mexelitine

58
New cards

Class Ic antiarrhythmics include? (two)

Flecainide, propafenone

59
New cards

Class II antiarrhythmics include? (three)

Beta blockers

Metoprolol

Esmolol

Labetalol

60
New cards

Class III antiarrhythmics include? (five)

Amiodarone

Dronedarone

Dofetilide

Sotalol

Labetalol

61
New cards

Class IV antiarrhythmics include? (two)

CCBs

Verapamil

Diltiazem

62
New cards

T/F: Amiodarone has class I, II, III, and IV effects.

True

63
New cards

Side effects associated with amiodarone?

Photosensitivity

Blue-gray skin discoloration

Hypothyroidism

Elevation of 2x or greater in UNL

Tremors, ataxia, peripheral neuropathy, insomnia

Corneal micro deposits

Optic neuropathy

64
New cards

Indication of dofetilide?

Maintenance of NSR in patients with highly symptomatic AF

65
New cards

Dosing for dofetilide?

500 mcg po BID

66
New cards

Renally adjusted dosing for dofetilide in patients with CrCl 40-60 mL/min?

250 mcg po BID

67
New cards

Renally adjusted dosing for dofetilide in patients with a CrCl < 40 mL/min?

125 mcg BID

68
New cards

T/F: Dofetilide is contraindicated in patients with a CrCl of less than 20 mL/min.

True

69
New cards

Contraindications associated with dofetilide?

Congenital or acquired long QT syndrome, concurrent use with verapamil, cimetidine, HCTZ, trimethoprim, itraconazole, ketoconazole, prochlorperazine, megestrol

70
New cards

Adverse effects associated with dofetilide?

HA, dizziness, syncope, insomnia, QT prolongation

71
New cards

T/F: Prior to administration of dofetilide, previous AAD should be held for at least 3 half-lives.

True

72
New cards

T/F: During its initiation phase, dofetilide can potentially increase the risk of TdP.

True

73
New cards

Dronedarone (Multaq) dosing?

400 mg PO BID

74
New cards

US boxed warning for Multaq says what?

Increased risk of death, stroke, and HF

75
New cards

T/F: Multaq is used in the treatment of AF in patients with NYHA class III and/or IV, or patients who have had an episode of decompensated HF in the past 4 weeks.

False; explicitly not used for these.

76
New cards

Adverse effects associated with Multaq?

Abdominal pain

Bradycardia

N/V/D

QT prolongation

TdP

77
New cards

T/F: Multaq is hepatotoxic.

True

78
New cards

Dronedarone vs. Amiodarone: Approved Uses

Dronedarone is approved for the treatment of paroxysmal or persistent AFib or AFlu (not permanent)

It is not for ventricular arrhythmias

Amiodarone is approved for the treatment of supraventricular and ventricular tachyarrhythmias (VF, VT, AF, AFlu)

79
New cards

Dronedarone vs. Amiodarone: Half-life

The half-life of dronedarone is 15 hours.

The half-life of amiodarone is 40-100 days.

80
New cards

Ibutilide (Corvert) IV dosing

Cardioversion only

< 60 kg: 0.01 mg/kg over 10 min

> or equal to 60 kg: 1 mg over 10 min

81
New cards

Adverse effects associated with ibutilide (Corvert)

Nonsustained VT, QT prolongation, TdP

82
New cards

For how long after administration of Ibutilide (Corvert) should ECG monitoring be done?

At least 4 hours, or until QTc has returned to baseline

83
New cards

Treatment for Torsades de Pointes includes? (four)

1. Magnesium sulfate 1-2g IV over 1-2 min

2. Beta-blockers (long-term treatment)

3. Permanent pacing

4. Implantable cardioverter-defibrillator

84
New cards

Adverse effects associated with propafenone?

AFlu, bradycardia, dizziness, dyspnea, HF exacerbation, taste disturbances, VT, visual disturbances

85
New cards

Cardioversion dosing for propafenone?

> or equal to 70 kg, 600 mg x 1

< 70 kg, 450 mg x 1

86
New cards

Maintenance dosing for propafenone?

150 - 300 mg PO q8h

ER 225 - 425 mg PO q12h

87
New cards

Adverse effects associated with flecainide?

AFlu, AV block, dizziness, dyspnea, HF exacerbation, HA, QT prolongation, VT, visual disturbances

88
New cards

Antiarrhythmic drugs that prolong QT?

Class I (especially Class Ia and III??)

89
New cards

Antibiotics that prolong QT?

quinolones and macrolides

90
New cards

Azole antifungals that prolong QT?

Fluconazole, ketoconazole, itraconazole, voriconazole

91
New cards

Antidepressants that prolong QT?

TCAs, SSRIs, SNRIs, mirtazapine, trazodone

92
New cards

Antiemetic agents that prolong QT?

5-HT3 receptor antagonists

Droperidol

Phenothiazines

93
New cards

Antipsychotics that prolong QT?

Most of them I think

94
New cards

In hospital initiation of dofetilide requires patients do be in the hospital how long?

At least 3 days; must remain in hospital at least 12 hours after conversion (~5 doses)

95
New cards

What lab values do we monitor for dofetilide?

Mg

K

SCr

96
New cards

Guidelines for who should not receive dronedarone?

NYHA class III or IV, or in patients who have had an episode of decompensated HF in the past 4 wks

97
New cards

Adverse effects associated with dronedarone?

GI upset, bradycardia, inc. SCr, QTc prolongation

98
New cards

T/F: Ibutilide (Corvert) is only administered IV for cardioversion.

True

99
New cards

Adverse effects associated with ibutilide?

Non-sustained VT, QT prolongation, TdP

100
New cards

For how long must patients be in the hospital to be administered sotalol?

At least 3 days